EUVIMED · CrossrefZeitschrift
Oncotarget
ISSN 1949-2553 · Impact Journals, LLC
Neueste Artikel
The biology of DHX9 and its potential as a therapeutic target
Cancer drug resistance: redox resetting renders a way
Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment
Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses
Moderate and strong static magnetic fields directly affect EGFR kinase domain orientation to inhibit cancer cell proliferation
Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study
Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment
The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma
Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein
Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cells
Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma
Limitation of the therapeutic potential of DUSP4 through adaptive feedback partially mediated by DUSP5
Assessment of genomic instability and homologous recombination repair in ovarian cancer using the Oncomine Comprehensive Assay Plus
Survival factors in lung cancer patients with mutations in the PROS1 , SERPINC1 , F2 , and F5 genes
Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023
Mechanism of anticancer action of bifidobacterium : Insights from gut microbiota
Statins exhibit anti-tumor potential by modulating Wnt/β-catenin signaling in colorectal cancer
A novel anti-human CD25 mAb with preferential reactivity to activated T regulatory cells depletes them from the tumor microenvironment
Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms
Molecular landscape of HER2-mutated non-small cell lung cancer in Northeastern Brazil: Clinical, histopathological, and genomic insights
Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis
Relationship between ABO blood group antigens and Rh factor with breast cancer: A systematic review and meta-analysis
Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies
METTL3 promotes oral squamous cell carcinoma by regulating miR-146a-5p/SMAD4 axis
Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells
Understanding the interplay between extracellular matrix topology and tumor-immune interactions: Challenges and opportunities
Targeting the multifaceted BRAF in cancer: New directions
Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management
The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response
EUVIMED